Catherine Dube to Colorectal Neoplasms
This is a "connection" page, showing publications Catherine Dube has written about Colorectal Neoplasms.
Connection Strength
0.661
-
Baxter NN, Facey M, Ruco A, Baker NA, Sorvari A, Benmessaoud A, Dube C, Rabeneck L, Tinmouth J. Nimble Approach: fast, adapting, calculating and ethically mindful approach to managing colorectal cancer screening programmes during a pandemic. BMJ Open Gastroenterol. 2022 01; 9(1).
Score: 0.150
-
Murthy SK, Antonova L, Dube C, Benchimol EI, Le Gal G, Hae R, Burke S, Ramsay T, Rostom A. Multivariable models for advanced colorectal neoplasms in screen-eligible individuals at low-to-moderate risk of colorectal cancer: towards improving colonoscopy prioritization. BMC Gastroenterol. 2021 Oct 18; 21(1):383.
Score: 0.147
-
Bishay K, Causada-Calo N, Scaffidi MA, Walsh CM, Anderson JT, Rostom A, Dube C, Keswani RN, Heitman SJ, Hilsden RJ, Shorr R, Grover SC, Forbes N. Associations between endoscopist feedback and improvements in colonoscopy quality indicators: a systematic review and meta-analysis. Gastrointest Endosc. 2020 11; 92(5):1030-1040.e9.
Score: 0.133
-
Hilsden RJ, Rose SM, Dube C, Rostom A, Bridges R, McGregor SE, Brenner DR, Heitman SJ. Defining and Applying Locally Relevant Benchmarks for the Adenoma Detection Rate. Am J Gastroenterol. 2019 08; 114(8):1315-1321.
Score: 0.126
-
Hilsden RJ, Bridges R, Dube C, McGregor SE, Naugler C, Rose SM, Rostom A, Heitman SJ. Defining Benchmarks for Adenoma Detection Rate and Adenomas Per Colonoscopy in Patients Undergoing Colonoscopy Due to a Positive Fecal Immunochemical Test. Am J Gastroenterol. 2016 Dec; 111(12):1743-1749.
Score: 0.104